Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth...

Frontiers in Oncology 2019 / 11 Vol. 9

Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)

Yang, Pei-Wen, Liu, Yu-Cheng, Chang, Ya-Han, Lin, Ching-Ching, Huang, Pei-Ming, Hua, Kuo-Tai, Lee, Jang-Ming, Hsieh, Min-Shu
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Journal:
Frontiers in Oncology
DOI:
10.3389/fonc.2019.01138
Date:
November, 2019
File:
PDF, 1.89 MB
2019
Conversion to is in progress
Conversion to is failed